Price
Financials
Standalone, Rs crore| Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 132 | 167 | 113 | 90 | 169 | 213 | 133 | 124 | 330 |
| Expenses | 119 | 144 | 107 | 84 | 152 | 187 | 125 | 110 | 295 |
| Operating Profit | 12 | 23 | 6 | 6 | 17 | 26 | 7 | 13 | 35 |
| OPM % | 9% | 14% | 6% | 7% | 10% | 12% | 6% | 11% | 11% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 |
| Interest | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
| Profit before tax | 10 | 20 | 3 | 2 | 13 | 21 | 4 | 10 | 30 |
| Tax % | 28% | 29% | 17% | 28% | 29% | 25% | 30% | 25% | 25% |
| Net Profit | 7 | 14 | 3 | 1 | 9 | 16 | 3 | 7 | 23 |
| EPS in Rs | 16.04 | 31.60 | 6.18 | 0.32 | 1.99 | 3.53 | 0.47 | 1.16 | 3.51 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 204 | 250 | 395 | 451 | 496 | 636 | 800 |
| Expenses | 188 | 235 | 370 | 412 | 447 | 571 | 718 |
| Operating Profit | 16 | 15 | 25 | 40 | 49 | 65 | 82 |
| OPM % | 8% | 6% | 6% | 9% | 10% | 10% | 10% |
| Other Income | 0 | 2 | 0 | 1 | 1 | 4 | 4 |
| Interest | 2 | 2 | 3 | 4 | 7 | 10 | 8 |
| Depreciation | 2 | 2 | 2 | 3 | 8 | 11 | 11 |
| Profit before tax | 12 | 12 | 20 | 33 | 35 | 48 | 66 |
| Tax % | 27% | 28% | 26% | 26% | 27% | 27% | |
| Net Profit | 9 | 9 | 15 | 25 | 26 | 35 | 49 |
| EPS in Rs | 20.09 | 19.98 | 33.04 | 54.96 | 5.70 | 5.49 | 8.67 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 26% | 17% | 48% | ||
| Compounded Profit Growth | % | 31% | 33% | 79% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | 25% | 24% | 17% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 45 | 64 |
| Reserves | 22 | 31 | 46 | 71 | 56 | 246 |
| Borrowings | 16 | 21 | 25 | 45 | 80 | 98 |
| Other Liabilities | 43 | 62 | 104 | 139 | 170 | 217 |
| Total Liabilities | 86 | 119 | 179 | 260 | 351 | 625 |
| Fixed Assets | 16 | 17 | 23 | 40 | 66 | 83 |
| CWIP | 0 | 0 | 0 | 9 | 11 | 22 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 70 | 102 | 157 | 210 | 275 | 520 |
| Total Assets | 86 | 119 | 179 | 260 | 351 | 625 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity | 8 | -0 | 6 | 15 | 6 | -70 |
| Cash from Investing Activity | -6 | -3 | -8 | -31 | -34 | -108 |
| Cash from Financing Activity | -2 | 4 | 1 | 17 | 28 | 183 |
| Net Cash Flow | 0 | 0 | -0 | 0 | 0 | 5 |
| Free Cash Flow | 2 | -3 | -2 | -15 | -28 | -109 |
| CFO/OP | 50% | 30% | 38% | 55% | 27% | -81% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 82 | 96 | 96 | 116 | 120 | 113 |
| Inventory Days | 53 | 44 | 49 | 84 | 154 | |
| Days Payable | 95 | 105 | 129 | 152 | 156 | |
| Cash Conversion Cycle | 82 | 54 | 35 | 37 | 52 | 110 |
| Working Capital Days | 32 | 31 | 31 | 30 | 26 | 71 |
| ROCE % | 30% | 35% | 38% | 28% | 20% |
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Promoters | 69.89% | 69.89% | 69.89% |
| FIIs | 4.42% | 2.58% | 3.82% |
| DIIs | 2.03% | 1.92% | 2.08% |
| Government | 0.60% | 0.00% | 0.00% |
| Public | 23.04% | 25.61% | 24.21% |
| No. of Shareholders | 14,925 | 13,386 | 13,285 |
Fundamentals
Market Cap₹ 773 Cr.
Current Price₹ 120
Stock P/E15.8
Book Value₹ 48.2
ROCE19.6 %
ROE17.2 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)48%
Compounded Profit Growth (TTM)79%
Standalone figures.
Valuation
Market capRs 751 Cr
Enterprise valueRs 772 Cr
P/E (TTM)21.29x
Price to book21.04x
Price to sales1.18x
EV / EBITDA11.49x
EV / EBIT13.72x
EV / sales1.21x
Earnings yield4.70%
Profitability
Operating margin (excl. other income)5.88%
Operating margin (incl. other income)6.72%
EBITDA margin10.53%
Pre-tax margin7.54%
Net profit margin5.53%
Net margin, latest quarter6.02%
ROE28.72%
ROCE29.75%
ROA8.78%
ROIC (approx.)72.24%
Tax rate27.56%
Other income / net worth5.85%
Growth
Sales growth (latest year)22.42%
Profit growth (latest year)-0.55%
Sales growth QoQ-6.60%
Profit growth QoQ147.84%
Sales growth YoY (latest quarter)37.90%
Profit growth YoY (latest quarter)421.68%
Per share
EPS (TTM)Rs 5.49
EPS (latest year)Rs 19.98
EPS (latest quarter)Rs 1.16
Book value per shareRs 5.55
Sales per shareRs 99.13
Cash flow per shareRs -0.02
Free cash flow per shareRs -16.94
Efficiency
Asset turnover2.10x
Fixed asset turnover14.59x
Inventory turnover7.43x
Inventory days49 days
Debtor days96 days
Debtors turnover3.78x
Creditor days156 days
Cash conversion cycle110 days
Working capital days71 days
Leverage
Total debtRs 21 Cr
Cash and bankRs 0 Cr
Net debtRs 21 Cr
Debt to equity0.59x
Net debt / EBITDA0.31x
Interest coverage6.90x
Current ratio (filing 2026-03-31)1.67x
Quick ratio (filing 2026-03-31)0.98x
Trade payables (filing 2026-03-31)Rs 209 Cr
Owners' fund to total sources30.03%
Debt to assets17.83%
Cash flow
Cash from Operating Activity (latest year)Rs -0 Cr
Cash from Investing Activity (latest year)Rs -3 Cr
Cash from Financing Activity (latest year)Rs 4 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -109 Cr
FCFE (approx.: FCF + change in debt)Rs -104 Cr
Cash from ops / profit, 5 years-0.39x
Statement figures
Net sales (TTM)Rs 638 Cr
Net sales (latest year)Rs 250 Cr
Sales (latest quarter)Rs 124 Cr
Operating profit excl. other income (latest year)Rs 15 Cr
Operating profit (latest quarter)Rs 13 Cr
Other income (TTM)Rs 4 Cr
EBITDA (TTM)Rs 67 Cr
PBDT (TTM)Rs 59 Cr
Profit before tax (TTM)Rs 48 Cr
Tax (latest year)Rs 3 Cr
Net profit (TTM)Rs 35 Cr
Net profit (latest year)Rs 9 Cr
Net profit (latest quarter)Rs 7 Cr
Depreciation (TTM)Rs 11 Cr
Depreciation (latest quarter)Rs 3 Cr
Interest (TTM)Rs 8 Cr
Cost of goods sold (latest year)Rs 219 Cr
Total expenditure (latest year)Rs 235 Cr
Total income (latest year)Rs 252 Cr
Share capitalRs 4 Cr
ReservesRs 31 Cr
Shareholders' fundsRs 36 Cr
Total assetsRs 119 Cr
Net blockRs 17 Cr
ReceivablesRs 66 Cr
InventoryRs 30 Cr
Other liabilitiesRs 62 Cr
Shares outstanding (crore)6.43
Ownership
Promoter holding69.89%
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | ADVANCE | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.6% | -2.8% | +1.2 pts |
| 1 month | +0.5% | -6.8% | +7.2 pts |
| 3 months | +2.6% | -7.6% | +10.2 pts |
| 6 months | +37.4% | +0.4% | +37.0 pts |
Red flags
F-score 3 of 8| explain | Weak cash conversion Cash from operations was 43% of net profit over the last 2 years |
| explain | Debt up, profit down Borrowings up 35% while net profit fell in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹330 Cr +95.3% vs Jun 2025.
Net profit ₹23 Cr +155.6%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| UPL Ltd | 45,402 | 23.0 | 10.1 % |
| P I Industries Ltd | 34,725 | 32.2 | 15.0 % |
| Sumitomo Chemical India Ltd | 21,521 | 37.7 | 23.5 % |
| Bayer CropScience Ltd | 16,191 | 22.1 | 29.1 % |
| Sharda Cropchem Ltd | 6,509 | 10.4 | 30.2 % |
| Dhanuka Agritech Ltd | 4,148 | 15.5 | 23.8 % |
| Rallis India Ltd | 3,882 | 17.0 | 14.1 % |
| Bhagiradha Chemicals & Industries Ltd | 3,128 | 114 | 4.53 % |
| NACL Industries Ltd | 3,101 | 120 | 8.13 % |
| GSP Crop Science Ltd | 2,198 | 21.0 | 18.9 % |
| Insecticides India Ltd | 1,706 | 13.6 | 15.8 % |
| Bharat Rasayan Ltd | 1,673 | 12.0 | 16.1 % |
| Astec Lifesciences Ltd | 1,552 | -5.44 % | |
| India Pesticides Ltd | 1,533 | 14.2 | 16.6 % |
| Meghmani Organics Ltd | 1,458 | 22.7 | 6.71 % |
| Date | Client | Side | Qty | Price |
|---|---|---|---|---|
| 2026-10-01 | L7 Hitech Private Limited | SELL | 350,000 | 116.75 |
| 2026-10-01 | Growvia Trade Private Limited | BUY | 350,000 | 116.75 |
No corporate actions on record.
| Date | Type | What it says |
|---|---|---|
| 2026-10-01 | Litigation | Receipt of a Show Cause-cum-Demand Notice from the GST Department under Regulation 30 of the SEBI Listing Regulations. |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.